About
Team
Pipeline
OPN-2853
OPN-7486
OPN-6602
OPN-9627
OPN-9840
OPN-FMRP
Patients
News
Press Releases
Publications
& Posters
Careers
Contact
General information
info@opnabio.com
Investor inquiries
bd@opnabio.com
Media and BD inquiries
bd@opnabio.com
OPN-6602
Select PROGRAMS
All Programs
OPN-2853
(8)
OPN-51107
(17)
OPN-6602
(1)
OPN-7486
(5)
Select Dates
All Dates
2023
(3)
2022
(1)
2021
(3)
2020
(3)
2019
(7)
2018
(4)
2017
(3)
2016
(2)
2015
(3)
October 14, 2023
Poster
OPN-6602, a dual EP300/CBP bromodomain inhibitor modulates androgen-driven transcription in mCRPC
AUTHORS
Matusow, et al
Programs
OPN-6602
Download PDF